Effects of epinephrine and the cyclic AMP phosphodiesterase inhibitor SQ 20009 on glucose and glycogen metabolism in skeletal muscle
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 28 (6) , 807-813
- https://doi.org/10.1016/0006-2952(79)90362-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of epinephrine and cyclic AMP phosphodiesterase inhibitors on the glycogen synthetic pathway and glucose content in skeletal muscleBiochemical Pharmacology, 1976
- 1-ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)—a potent new inhibitor of cyclic 3′,5′-nucleotide phosphodiesterasesBiochemical Pharmacology, 1972
- A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucoseAnalytical Biochemistry, 1968
- The effect of metabolic inhibitors on the response of the perfused rat heart to epinephrineBiochemical Pharmacology, 1967
- Activation of Skeletal Muscle Phosphorylase b Kinase by CA2+ *Biochemistry, 1964
- Influence Of Epinephrine and Insulin on Uridine Diphosphate Glucose-α-Glucan Transferase and Phosphorylase in MuscleNature, 1964
- Determination of glycogenArchives of Biochemistry and Biophysics, 1957
- The effect of epinephrine and other glycogenolytic agents on the phosphorylase A content of muscleBiochimica et Biophysica Acta, 1956
- The Effect of Adrenaline on the Uptake of Glucose, Mannose and Fructose in the Rat Diaphragm.Acta Physiologica Scandinavica, 1955
- MAMMALIAN CARBOHYDRATE METABOLISMPhysiological Reviews, 1931